Jove
Visualize
联系我们

相关概念视频

Inflammation01:38

Inflammation

52.5K
Overview
52.5K
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

10.9K
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
10.9K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

156
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
156
Inflammatory Response II: Inflammatory Exudate and Tissue Repair01:24

Inflammatory Response II: Inflammatory Exudate and Tissue Repair

4.7K
The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
4.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Therapeutic hypothermia in ECPR: re-examining neuroprotection in refractory cardiac arrest.

Intensive care medicine experimental·2025
Same author

Manganism in an End-Stage Renal Disease Patient on Maintenance Hemodialysis.

Annals of Indian Academy of Neurology·2025
Same author

Lurking Danger: Emerging Evidence.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine·2024
Same author

Recent advancements in critical care: Part I.

Indian journal of anaesthesia·2023
Same author

Recent advances in critical care: Part II.

Indian journal of anaesthesia·2023
Same author

Recommendations for Evaluation and Selection of Deceased Organ Donor: Position Statement of ISCCM.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine·2023
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jun 3, 2025

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
05:56

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

Published on: February 20, 2021

2.0K

解码炎症:预测ICU中的败血症

Balasubrahmanyam Chandrabhatla1, Anitha A V1, Lakshmi Sasidhar Puvvula1

  • 1Department of Critical Care Medicine, Citizens Specialty Hospital, Hyderabad, IND.

Cureus
|January 8, 2025
PubMed
概括
此摘要是机器生成的。

单细胞分布宽度 (MDW) 和平均单细胞体积 (MMV) 是早期败血症指标. 这些生物标志物来源于全血细胞计 (CBC) 测试,可以帮助诊断败血症,特别是在资源有限的环境中.

关键词:
败血症中的生物标志物早期的败血症是什么炎症生物标志物的生物标志物炎症生物标志物用于ICU中败血症的发展.单细胞的平均体积 (mmv)单细胞的分布宽度 (mdw)资源有限的设置 资源有限的设置败血症预测的预测

更多相关视频

A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

144
Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
05:28

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

3.4K

相关实验视频

Last Updated: Jun 3, 2025

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
05:56

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

Published on: February 20, 2021

2.0K
A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

144
Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
05:28

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

3.4K

科学领域:

  • 关键护理医学 关键护理医学
  • 实验室血液学 实验室血液学
  • 生物标志物发现发现

背景情况:

  • 败血症是一种危及生命的器官功能障碍,是由宿主对感染的反应失调引起的.
  • 传统的临床症状和目前的败血症查得分缺乏足够的准确性.
  • 对可靠和可访问的生物标志物对于早期毒症检测有极大需求.

研究的目的:

  • 评估六种炎症生物标志物对ICU患者败血症发展的预测能力.
  • 评估这些生物标志物与败血症相关结果的关联,包括死亡率和器官功能障碍.
  • 在资源有限的环境中确定用于败血症诊断的经济有效的生物标志物.

主要方法:

  • 在ICU环境中进行了前性观察研究.
  • 从全血细胞计 (CBC) 样本中分析了六种生物标志物 (CRP,RDW,NLR,MDW,MNV,MMV).
  • 收集了人口统计数据,临床进展和严重程度得分 (APACHE II,SOFA).

主要成果:

  • 单细胞分布宽度 (MDW) 显示为0.932的曲线下的最大面积 (AUC) 用于败血症预测.
  • MDW,平均中性粒细胞体积 (MNV) 和平均单细胞体积 (MMV) 显示出100%的特异性.
  • MDW和MMV与败血症预测有显著的相关性,MDW在测试的生物标志物中显示出最高的特异性 (86.84%).

结论:

  • 从常规CBC测试中获得的生物标志物,特别是MDW和MMV,显示出早期败血症诊断的重大潜力.
  • 这些可访问的生物标志物可以在资源有限的环境中成为有价值的工具,以改善败血症检测.
  • 进一步验证MDW和MMV可能会增强败血症管理协议.